Mediolanum International Funds Ltd Invests $8.16 Million in Synopsys, Inc. $SNPS

Mediolanum International Funds Ltd acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 21,290 shares of the semiconductor company’s stock, valued at approximately $8,157,000.

A number of other institutional investors have also recently bought and sold shares of the company. Sankala Group LLC acquired a new position in Synopsys in the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Synopsys during the 4th quarter valued at about $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys during the 4th quarter valued at about $28,000. Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys in the 4th quarter valued at approximately $32,000. Finally, Geneos Wealth Management Inc. increased its holdings in Synopsys by 151.5% in the first quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock worth $33,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In other news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the stock. Bank of America lifted their target price on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Needham & Company LLC restated a “buy” rating and set a $580.00 price target on shares of Synopsys in a report on Thursday, May 28th. Rosenblatt Securities lifted their price objective on shares of Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a research note on Tuesday, May 26th. KeyCorp reiterated an “overweight” rating on shares of Synopsys in a report on Thursday, May 28th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $570.06.

Read Our Latest Report on SNPS

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

Synopsys Price Performance

Shares of Synopsys stock opened at $378.46 on Tuesday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The firm has a fifty day simple moving average of $466.55 and a 200-day simple moving average of $457.80. The stock has a market capitalization of $72.47 billion, a price-to-earnings ratio of 87.61, a PEG ratio of 2.26 and a beta of 1.22. Synopsys, Inc. has a 1-year low of $366.00 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. Synopsys’s revenue was up 41.9% compared to the same quarter last year. During the same period last year, the business posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.